Effects of immunosuppressant FTY720 on renal and hepatic hemodynamics in the rat

Transplantation

Volumn 74, Issue 5, 2002, Pages 602-610

  Tawadrous, Michael N ^a   Mabuchi, Ayako ^a   Zimmermann, Arthur ^a   Wheatley, Antony M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEMODYNAMICS; HISTOLOGY; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY TUBULE; LIVER CELL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; TRANSPLANTATION; WEIGHT REDUCTION;

EID: 0037106491     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209150-00004     Document Type: Article

References (50)

1. Naef M, Baer HU, Glaser C, et al. Evaluation of laser Doppler flowmetry to assess cyclosporine A-induced impairment of renal blood flow. Journal of Surgical Research 1998; 75 (2); 161.
2. Gruber SA, Skjei KL, Sothern RB, et al. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Transplantation Proceedings 1991; 23 (1 Pt 2): 1104.
3. Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney International 1988; 33 (2): 590.
4. Shulman H, Striker G, Deeg HJ, Kennedy M, et al. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med 1981; 305 (23): 1392.
5. Spencer CM, Goa KL, Gillis JC. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997; 54 (6): 925.
6. Binet I, Wallnofer A, Weber C, et a. Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A. Kidney International 2000; 57 (1): 224.
7. Darlametsos IE, Papanikolaou EN, Varonos DD. Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems. Prostaglandins Leukotrienes & Essential Fatty Acids 2000; 63 (5): 263.
8. Cottet-Maire F, Avdonin PV, Roulet E, et al. Upregulation of vasopressin V-1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment. British Journal of Pharmacology 2001; 132 (4): 909.
9. Guieu R, Dussol B, Devaux C, et al. Interactions between cyclosporine A and adenosine in kidney transplant recipients. Kidney International 1998; 53 (1): 200.
10. Brinkmann V, Chen S, Feng L, et al. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression. Transplantation Proceedings 2001; 33 (1-2): 530.
11. Suzuki S. FTY720: mechanisms of action and its effect on organ transplantation. Transplantation Proceedings 1999; 31 (7): 2779.
12. Fujita T, Inoue K, Yamamoto S, et al. Fungal metabolites. Part 12. Potent immunosuppressant, 14-deoxomyriocin, (2S,3R,4R)-(E)-2-amino-3,4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure-activity relationships of myriocin derivatives. Journal of Antibiotics 1994; 47 (2): 216.
13. Pinschewer DD, Ochsenbein AF, Odermatt B, et al. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. Journal of Immunology 2000; 164 (11): 5761.
14. Chiba K, Hoshino Y, Suzuki C, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplantation Proceedings 1996; 28 (2): 1056.
15. Hoshino Y, Suzuki C, Ohtsuki M, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplantation Proceedings 1996; 28 (2): 1060.
16. Masubuchi Y, Kawaguchi T, Ohtsuki M, et al. FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats. Transplantation Proceedings 1996; 28 (2): 1064.
17. Kawaguchi T, Hoshino Y, Rahman F, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplantation Proceedings 1996; 28 (2): 1062.
18. Suzuki S, Li XK, Shinomiya T, et al. Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720. Transplantation Proceedings 1996; 28 (4): 2049.
19. Suzuki K, Kazui T, Kawabe A, et al. Immunosuppressive effect of FTY 720 on rat pancreas allograft. Transplantation Proceedings 1998; 30 (7): 3417.
20. Watanabe H, Hamada Y, Toshima T, et al. Effect of a new immunosuppressant, FTY720, on joint allografts. Journal of Reconstructive Microsurgery 1999; 15 (4): 295.
21. Stepkowski SM, Wang M, Qu X, et al. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival. Transplantation Proceedings 1998; 30 (5): 2214.
22. Suzuki K, Yan H, Li XK, et al. Prevention of Experimentally Induced Autoimmune Type I Diabetes in Rats by the New Immunosuppressive Reagent Fry720. Transplantation Proceedings 1998; 30 (4): 1044.
23. Kitabayashi H, Isobe M, Watanabe N, et al. M. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. Journal of Cardiovascular Pharmacology 2000; 35 (3): 410.
24. Matsuura M, Imayoshi T, Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. International Journal of Immunopharmacology 2000; 22 (4): 323.
25. Tamura A, Li XK, Funeshima N, et al. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Surgery 2000; 127 (1); 47.
26. Tamura A, Li XK, Funeshima N, Enosawa S, et al. Combination effect of tacrolimus and FTY720 in liver transplantation in rats. Transplantation Proceedings 1999; 31 (7): 2785.
27. Yamashita K, Nomura M, Omura T, et al. Effects of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. Transplantation Proceedings 1999; 31 (1-2): 1178.
28. Wheatley AM, Zhao D. Intraoperative assessment by laser Doppler flowmetry of hepatic perfusion during orthotopic liver transplantation in the rat. Transplantation 1993; 56 (6): 1315.
29. Emi D, Banic A, Wheatley AM, Sigurdsson GH. Haemorrhage during anaesthesia and surgery: continuous measurement of microcirculatory blood flow in the kidney, liver, skin and skeletal muscle. European Journal of Anaesthesiology 1995; 12 (4): 423.
30. Hammad FT, Davis G, Zhang XY, et al. Intra- and post-operative assessment of renal cortical perfusion by laser Doppler flowmetry in renal transplantation in the rat. European Surgical Research 2000; 32 (5): 284.
31. Almond NE, Wheatley AM. Measurement of hepatic perfusion in rats by laser Doppler flowmetry. American Journal of Physiology 1992; 262 (2 Pt 1): G203.
32. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circulation Research 1980; 47 (1): 1.
33. Van Riemsdijk IC, Mulder PG, De Fijter JW, et al. Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: A double-blind, randomized, placebo-controlled, multicenter study. Transplantation 2000; 70 (1): 122.
34. Suzuki S, Enosawa S, Kakefuda T, et al. A Novel immunosuppressant, FTY720, with a Unique Mechanism of Action, Induces Long-Term Graft Acceptance in Rat and Dog Allotransplantation. Transplantation 1996; 61 (2): 200.
35. Nikolova Z, Hof A, Rudin M, et al. Prevention of graft vessel disease by combined FTY720/cyclosporine A treatment in a rat carotid artery transplantation model. Transplantation 2000; 69 (12): 2525.
36. Li XK, Tamura A, Fujino M, et al. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720. Clinical & Experimental Immunology 2001; 123 (2): 331.
37. Yagi H, Kamba R, Chiba K, et al. Immunosuppressant FTY720 inhibits thymocyte emigration. European Journal of Immunology 2000; 30 (5): 1435.
38. Brinkmann V, Pinschewer D, Chiba K, Feng L. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends in Pharmacological Sciences 2000; 21 (2): 49.
39. Chiba K, Yanagawa Y, Masubuchi Y, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. Journal of Immunology 1998; 160 (10): 5037.
40. Brinkmann V, Pinschewer DD, Feng L, et al. FTY720: Altered lymphocyte traffic results in allograft protection. Transplantation 2001; 72 (5): 764.
41. Rosen SM. Effects of anaesthesia and surgery on renal haemodynamics. British Journal of Anaesthesia 1972; 44 (3): 252.
42. Kett MM. Renal vascular resistance properties and glomerular protection in early established SHR hypertension. Journal of Hypertension 2001; 19 (8): 1505.
43. Van Dokkum RP. Impaired autoregulation of renal blood flow in the fawn-hooded rat. American Journal of Physiology 1999; 276 (1 Pt 2): R189.
44. Tawadrous MN, Zhang XY, Wheatley AM. Microvascular origin of laserDoppler flux signal from the surface of normal and injured liver of the rat. Microvascular Research 2001; 62 (3): 355.
45. Wheatley AM, Almond NE. Effect of hepatic nerve stimulation and norepinephrine on the laser Doppler flux signal from the surface of the perfused rat liver. International Journal of Microcirculation: Clinical & Experimental 1997; 17 (1): 48.
46. Hemingway DM, Angerson WJ, Anderson JH, et al. TG. Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II. British Journal of Cancer 1992; 66 (5): 958.
47. Hammad FT, Davis G, Zhang X, Wheatley AM. The role of endothelin in early renal cortical reperfusisn in renal transplantation. European Surgical Research 2000; 32 (6): 380.
48. Wheatley AM, Almond NE, Stuart ET, Zhao D. Interpretation of the laser Doppler flow signal from the liver of the rat. Microvascular Research 1993; 45 (3): 290.
49. Kahan BD. FTY720: a new immunosuppressive agent with novel mechanism(s) of action. Transplantation Proceedings 1998; 30 (5): 2210.
50. Mizuta K, Ohmori M, Miyashita F, et al. Effect of pretreatment with FTY720 and cyclosporin on ischaemia-reperfusion injury of the liver in rats. Journal of Pharmacy & Pharmacology 1999; 51 (12): 1423.